According to a national survey of 800 primary care physicians conducted by Pri-Med Institute, Boston, almost three-quarters of physicians who participated said that commercial support of CME by pharmaceutical companies is a good thing. Just 8 percent said they were less likely to attend a CME program that is underwritten by pharma funds, and only 10 percent viewed industry support as “negative.” Regardless of their feelings, an overwhelming 86 percent said whether a program is supported by ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.